Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and endometriosis.
News-Medical.Net on MSN
Five-year project seeks new weapons against drug-resistant bacteria
Lethal lettuce in Missouri. Murderous onions in Colorado. To biochemists at the University of Oklahoma, these aren't just ...
Think of a highly nutritious and versatile food enjoyed by people worldwide, and the first name that pops up in mind is "egg.
The India Gentamycin market is driven by rising bacterial infections and antimicrobial resistance, supported by government ...
Animal tests show promise to target invasive strain of E. coli but approval for use in humans is still years away ...
Ashtabula Area City School District sued Liberty Mutual Fire Insurance Company in federal court this month, alleging the ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
DENVER, CO / ACCESS Newswire / November 4, 2025 / ForCast Orthopedics, a development-stage company focused on modernizing care for complex orthopedic infections, today announced that the US Food and ...
Antimicrobial resistance (AMR) is one of the world’s most urgent health challenges, with the WHO’s new report showing there are ‘too few antibacterials in the pipeline’. Most of the ‘low-hanging fruit ...
Researchers Ni Guohua and Associate Researcher Sun Hongmei from the Institute of Plasma Physics, together with Associate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback